Bioresorbable vascular scaffold: a step back thinking of the future

Delayed disruption of a bioresorbable vascular scaffold.

(A) Pre-procedural angiogram demonstrating a focal lesion at left circum previously implanted in the ostial left anterior descending artery (LAD). implantation of a 3.5 12.0 mm bioresorbable vascular scaffold (BVS) 3.5-mm noncompliant balloon. (C) The 6-month follow-up angiogram sh follow-up angiogram after gentle pre-dilation with a 2.0-mm balloon per order to obtain optical coherence tomograp...

Balloon postdilatation is a mandatory step in the deployment of bioresorbable vascular scaffold

Bioresorbable Vascular Scaffold Korean Expert Panel Report

Bioresorbable vascular scaffold (BRS) is an innovative device that provides structural support and drug release to prevent early recoil or restenosis, and then degrades into nontoxic compounds to avoid late complications related with metallic drug-eluting stents (DESs). BRS has several putative advantages. However, recent randomized trials and registry studies raised clinical concerns about the...

Vascular Healing of a False Lumen After Bioresorbable Scaffold Implantation.

Bioresorbable scaffolds (BRS) are promising devices for the treatment of coronary artery disease by virtue of their resorption properties allowing positive vascular remodeling. This case report illustrates the vascular healing process after Absorb BRS (Abbott Vascular, Santa Clara, CA) implantation in a false lumen during the treatment of a chronic total occlusion. A 62-year-old male with stabl...

Bioresorbable Scaffold: The Emerging Reality and Future Directions.

In the era of drug-eluting stents, large-scale randomized trials and all-comer registries have shown excellent clinical results. However, even the latest-generation drug-eluting stent has not managed to address all the limitations of permanent metallic coronary stents, such as the risks of target lesion revascularization, neoatherosclerosis, preclusion of late lumen enlargement, and the lack of...